Tarsus appoints Elizabeth Yeu as CMO; she resigns from board

Tarsus Pharmaceuticals, Inc.

Dr. Yeu appointed Chief Medical Officer effective Nov 4, 2024; resigned from Board same date.
Annual base salary of $480,000, $25,000 signing bonus, and 45% annual incentive bonus.
Granted 27,278 RSUs vesting 25% annually over four years, and option for 41,074 shares.
Severance includes 12 months salary and benefits; accelerated vesting on change in control.
Dr. Yeu previously served as board member since Dec 2021 and consulting Chief Medical Advisor.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Elizabeth Yeu

Chief Medical Officer

TARS · Tarsus Pharmaceuticals, Inc.

Effective: 2024-11-04
Filed: November 5, 2024, 6:59 PM ET

On November 5, 2024, Tarsus Pharmaceuticals, Inc. (the "Company") announced the appointment of Elizabeth Yeu, M.D. as the Company's Chief Medical Officer, effective as of November 4, 2024 (the "Effective Date").

Departed

Elizabeth Yeu

Member of the Board of Directors

TARS · Tarsus Pharmaceuticals, Inc.

Effective: 2024-11-04
Filed: November 5, 2024, 6:59 PM ET

In connection with the appointment, on November 1, 2024, Dr. Yeu resigned as a member of the Company's board of directors (the "Board") and from the committees of the Board on which she served, each effective as of the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Elizabeth Yeu was appointed as Chief Medical Officer at Tarsus Pharmaceuticals, Inc..

Action: appointed
Role: Chief Medical Officer

Exact text from the filing

On November 5, 2024, Tarsus Pharmaceuticals, Inc. (the "Company") announced the appointment of Elizabeth Yeu, M.D. as the Company's Chief Medical Officer, effective as of November 4, 2024 (the "Effective Date").

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Elizabeth Yeu resigned as Member of the Board of Directors at Tarsus Pharmaceuticals, Inc..

Action: resigned
Role: Member of the Board of Directors

Exact text from the filing

In connection with the appointment, on November 1, 2024, Dr. Yeu resigned as a member of the Company's board of directors (the "Board") and from the committees of the Board on which she served, each effective as of the Effective Date.

View on SEC.gov

Tarsus Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001819790-24-000119

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.